Short-term resistance to diet-induced obesity in A/J mice is not associated with regulation of hypothalamic neuropeptides

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 4 50-4, 2004, Pages

  Bullen Jr , John W ^a   Ziotopoulou, Mary ^a   Ungsunan, Linda ^a   Misra, Jatin ^a   Alevizos, Ilias ^a   Kokkotou, Efi ^b   Maratos Flier, Eleftheria ^b   Stephanopoulos, Gregory ^a   Mantzoros, Christos S ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Energy homeostasis; Interleukin 1; Microarray; Neuropeptides; Uncoupling protein 2

Indexed keywords

ANOREXIGENIC AGENT; APPETITE STIMULANT; CORTICOSTERONE; FATTY ACID; GLUCOSE; INSULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MESSENGER RNA; NEUROPEPTIDE; TRANSFORMING GROWTH FACTOR BETA; UNCOUPLING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENERGY; FEEDING; FOOD INTAKE; GENE CONTROL; HOMEOSTASIS; HYPOTHALAMUS; LIPID DIET; METABOLIC REGULATION; MOLECULE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADIPOSE TISSUE, BROWN; ANIMALS; BODY WEIGHT; DIET; DIETARY FATS; DNA PRIMERS; EATING; ENERGY INTAKE; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; GENE LIBRARY; HYPOTHALAMUS; IN SITU HYBRIDIZATION; INTERLEUKIN-1; ION CHANNELS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED A; MITOCHONDRIAL PROTEINS; NEUROPEPTIDES; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 4544253222     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00114.2004     Document Type: Article

References (49)

1. Bergin HT, Mizuno T, Taylor J, and Mobbs CV. Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus. Brain Res 851: 198-203, 1999.
2. Bjørbæk C, El-Haschimi K, Frantz JD, and Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 274: 30059-30065, 1999.
3. Bjørbæk C, Elmquist J, El-Haschimi K, Kelly J, Ahima RS, Hileman S, and Flier JS. Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neutrophic factor. Endocrinology 140: 2035-2043, 1999.
4. Boengler K, Pipp F, Fernandez B, Richter A, Schaper W, and Deindl E. The ankyrin repeat containing SOCS box protein 5: a novel protein associated with arteriogenesis. Biochem Biophys Res Commun 302: 17-22, 2003.
5. Chemeli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Safer CB, and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451, 1999.
6. Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, and Tremblay ML. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2: 497-503, 2002.
7. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himmus-Hagen J, Chan C, Ramachandran C, Gresser MJ, Tremblay ML, and Kennedy BP. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283: 1544-1548, 1999.
8. El-Haschimi K, Pierroz DD, Hileman SM, Bjørbaek C, and Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105: 1827-1832, 2000.
9. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, and Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol Regul Integr Comp Physiol 276: R136-R142, 1999.
10. Fan W, Boston BA, Keterson RA, Hruby VJ, and Cone RD. Role of melanocortinergic neurons in feeding and the Agouti obesity syndrome. Nature 385: 165-168, 1997.
11. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seidin MF, Surwit RS, Ricquier D, and Warden CH. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15: 269-272, 1997.
12. Flier J and Maratos-Flier E. Energy homeostasis and body weight. Curr Biol 10: R215-R217, 2000.
13. Friedman JM and Halaas JL. Leptin and the regulation of body weight. Curr Biol 10: 763-770, 2000.
14. Gabay C, Dreyer MG, Pellegrinelli N, Chicheportiche R, and Meier CA. Leptin directly induces secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86: 783-791, 2001.
15. Giraudo SQ, Kotz CM, Grace MK, Levine AS, and Billington CJ. Rat hypothalamic NPY mRNA and brown fat uncoupling protein mRNA after high-carbohydrate or high-fat diets. Am J Physiol Regul Integr Comp Physiol 266: R1578-R1583, 1994.
16. Hanada M, Ninomiya-Tsuji J, Komaki K, Ohnishi M, Katsura K, Kanamaru R, Matsumoto K, and Tamura S. Regulation of the TAK1 signaling pathway by protein phosphatase 2C. J Biol Chem 276: 5753-5759, 2000.
17. Hillebrand JJG, de Wied D, and Adan RAH. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 23: 2283-2306, 2002.
18. Hilton DJ. Negative regulators of cytokine signal transduction. Cell Mol Life Sci 55: 1568-1577, 1999.
19. Hosoi T, Okuma Y, and Nomura Y. Leptin regulates interleukin-1β expression in the brain via the STAT3-independent mechanisms. Brain Res 949: 139-146, 2002.
20. Juge-Aubry C and Meier CA. Immunomodulatory actions of leptin. Mol Cell Endocrinol 194: 1-7, 2002.
21. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, and Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20: 68-100, 1999.
22. Klaman L, Boss O, Peroni O, Kim J, Martino J, Zabalotny J, Moghal N, Lubkin M, Kim Y, Sharpe A, Stricker-Kongrad A, Shulman G, Neel B, and Kahn B. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20: 5479-5489, 2000.
23. Kokkotou E, Tritos N, Mastaitis J, Slieker L, and Maratos-Flier E. Melanin-concentrating hormone receptor is a target of leptin action in the mouse brain. Endocrinology 142: 680-686, 2001.
24. Ludwig DS, Mountjoy KG, Tatro JB, Gillette JA, Frederich RC, Flier JS, and Maratos-Flier E. Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol Endocrinol Metab 274: E627-E633, 1998.
25. Masaki T, Yoshimichi G, Chiba S, Yasuda T, Noguchi H, Kakuma T, Sakata Y, and Yoshimatsu H. Corticotropin-releasing hormone-mediated pathway of leptin to regulate feeding, adiposity, and uncoupling protein expression in mice. Endocrinology 144: 3547-3554, 2003.
26. Matsuki T, Horai R, Sudo K, and Iwakura Y. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med 198: 877-888, 2003.
27. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, and Mobbs CV. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47: 294-297, 1998. [Corrigenda. Diabetes 47: April 1998, p. 696.]
28. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, and Mobbs CV. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47: 294-297, 1998. [Corrigenda. Diabetes 47: April 1998, p. 696.]
29. Peters W, te Morsche R, and Roelofs H. Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome. J Hepatol 38: 3-8, 2003.
30. Plata-Salaman C and Ilyin S. Interleukin-1β(IL-1β)-induced modulation of the hypothalamus IL-1β system, tumor necrosis factor-α, and transforming growth factor-1β mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: implications to IL-1β feedback systems and cytokine-cytokine interactions. J Neurosci Res 49: 541-550, 1997.
31. Prpic V, Watson PM, Frampton IC, Sabol MA, Jezek GE, and Gettys TW. Differential mechanisms and development of leptin resistance in A/J versus C57BL/6J mice during diet-induced obesity. Endocrinology 144: 1155-1163, 2003.
32. Prpic V, Watson PM, Frampton IC, Sabol MA, Jezek GE, and Gettys TW. Adaptive changes in adipocyte gene expression differ in AKR/J and SWR/J mice during diet-induced obesity. J Nutr 132: 3325-3332, 2002.
33. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Pryspek R, Kanarek R, and Maratos-Flier E. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380: 243-247, 1996.
34. Rebuffe-Scrive M, Surwit R, Feinglos M, Kuhn C, and Rodin J. Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. Metabolism 42: 1405-1409, 1993.
35. Rosenbaum M, Leibel RL, and Hirsch J. Obesity. N Engl J Med 337: 396-407, 1997.
36. Sakurai T, Amemiya A, Ishii M, Matsuka I, Chemeli RM, Tanaka H, Williams SC, Richarson JA, Kozlowski GP, and Wilson S. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
37. Shimada M, Tritos NA, Lowell BB, Flier JS, and Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396: 670-674, 1998.
38. Starr R and Hilton DJ. Negative regulation of the JAK/STAT pathway. Bioessays 21: 47-52, 1999.
39. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, and Rebuffe-Scrive M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44: 644-651, 1995.
40. Surwit RS, Petro AE, Parekh P, and Collins S. Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice. Diabetes 46: 1516-1520, 1997.
41. Surwit RS, Wang S, Petro AE, Sanchis D, Raimbault S, Ricquier D, and Collins S. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci USA 95: 4061-4065, 1998.
42. Taheri S, Ward H, Ghatei M, and Bloom S. Role of orexins in sleep and arousal mechanisms. Lancet 335: 847, 2000.
43. Ukkola O and Santaniemi M. Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities. J Intern Med 251: 467-475, 2002.
44. Watson PM, Commins SP, Beiler RJ, Hatcher HC, and Gettys TW. Differential regulation of leptin expression and function in A/J vs. C57BL/6J mice during diet-induced obesity. Am J Physiol Endocrinol Metab 279: E356-E365, 2000.
45. West DB, Waguespack J, and McCollister S. Dietary obesity in the mouse: interaction of strain with diet composition. Am J Physiol Regul Integr Comp Physiol 268: R658-R665, 1995.
46. Wlk M, Wang CC, Venihaki M, Liu J, Zhao D, Anton PM, Mykoniatis A, Pan A, Zacks J, Karalis K, and Pothoulakis C. Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in mouse ileum. Gastroenlerology 123: 505-515, 2002.
47. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, and Matsuraoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270: 2008-2011, 1995.
48. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, and Neel BG. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2: 489-495, 2002.
49. Ziotopoulou M, Mantzoros CS, Hileman SM, and Flier JS. Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 279: E838-E845, 2000.